Homocysteine and Redox Signaling
- 1 May 2005
- journal article
- review article
- Published by Mary Ann Liebert Inc in Antioxidants and Redox Signaling
- Vol. 7 (5-6) , 547-559
- https://doi.org/10.1089/ars.2005.7.547
Abstract
Homocysteine is a thiol-containing amino acid that has gained notoriety because its elevation in the plasma is correlated with complex and multifactorial diseases, including cardiovascular diseases, neurodegenerative diseases, and neural tube defects. Homocysteine is redox-active, and its toxic effects have been frequently attributed to direct or indirect perturbation of redox homeostasis. Although the literature on the pathophysiology of elevated homocysteine is rather extensive, a very wide range of concentrations of this amino acid has been used in these studies ranging from normal to pathophysiological to unphysiological. It is clear that homocysteine induces varied responses that are specific to cell type and that cells, depending on their origin, display a wide range of sensitivity to homocysteine. In this review, we focus on the redox signaling pathways that have been connected to homocysteine in vascular (endothelial and smooth muscle) cells and in neuronal cells. We also discuss redox regulation of the key enzymes involved in homocysteine clearance: methionine synthase, betaine-homocysteine methyltranferase, and cystathionine beta-synthase.Keywords
This publication has 100 references indexed in Scilit:
- Activation of cystathionine synthase by adenosylmethionine and adenosylethioninePublished by Elsevier ,2005
- l-homocysteine and l-homocystine stereospecifically induce endothelial nitric oxide synthase-dependent lipid peroxidation in endothelial cellsFree Radical Biology & Medicine, 2004
- Homocysteine Induces 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase in Vascular Endothelial CellsCirculation, 2002
- Homocysteine and strokeCurrent Opinion in Neurology, 2001
- Enhanced In Vivo Lipid Peroxidation at Elevated Plasma Total Homocysteine LevelsArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- ERK2 Activation by Homocysteine in Vascular Smooth Muscle CellsBiochemical and Biophysical Research Communications, 1998
- HOMOCYSTEINE AND VASCULAR DYSFUNCTIONLife Sciences, 1997
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- The Acid Strength of the -SH Group in Cysteine and Related CompoundsJournal of the American Chemical Society, 1955